Currently submitted to: JMIR Cancer
Date Submitted: Jul 10, 2026
Open Peer Review Period: Jul 17, 2026 - Sep 11, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Feasibility, Acceptability, Usability, and Preliminary Clinical Outcomes of the WithYou PINK Mental Health App for Breast Cancer Survivors: A Pilot Study
ABSTRACT
Background:
Breast cancer is the most diagnosed cancer among women worldwide. Although many survivors experience anxiety, depression, and other psychological challenges during survivorship, access to mental health care is often limited by clinician shortages, cost, and time. Mobile health applications may offer an accessible, scalable, and low-cost approach for delivering psychological support.
Objective:
This study evaluated the feasibility, acceptability, usability, and preliminary mental health outcomes of WithYou PINK, an app co-designed with breast cancer survivors and grounded in Acceptance and Commitment Therapy (ACT).
Methods:
This 6-week single-arm pilot study was conducted from March to May 2026 in Indianapolis, Indiana, USA. Eligible participants were diagnosed with stage I–III breast cancer, had completed primary treatment within the previous 5 years, and reported moderate to severe anxiety (Generalized Anxiety Disorder-7 [GAD-7] score ≥10) and/or moderate depressive symptoms (Patient Health Questionnaire-8 [PHQ-8] score 10–19) at screening. Participants used the WithYou PINK app, which included 40 ACT-based activities designed to support adaptive coping. Feasibility was assessed through intervention completion, while acceptability and usability were evaluated using the Acceptability E-Scale (AES) and System Usability Scale (SUS). Changes in anxiety, depression, other mental health outcomes, and quality of life were examined using pre-post assessments.
Results:
Participants (N=34) had a mean age of 52.7 years (SD = 10.7), and all were female. More than half (55.9%) of study participants completed all 40 activities in the app, demonstrating feasibility. Mean AES (27.6) and SUS (87.9) scores exceeded established thresholds for good acceptability and usability. Pre-post analyses demonstrated statistically and clinically significant improvements in anxiety (GAD-7: g = -1.30, 95% CI -1.75 to -0.84; p < .001), depressive symptoms (PHQ-8: g = -1.33, 95% CI -1.78 to -0.86; p < .001), and other mental health outcomes, with more modest improvements in quality of life.
Conclusions:
The WithYou PINK app demonstrated feasibility, acceptability, and usability among breast cancer survivors with elevated symptoms of anxiety and/or depression. Improvements in mental health outcomes observed over the 6-week intervention support the potential of this ACT-based app. A robust clinical trial is needed to provide the rigorous evidence necessary to justify clinical implementation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.